REFERENCE USED FOR NUMBERS 1 -138:

CANTORIA, Magdalena C. Pharmacognosy in Action: The Study of Drugs of Biological

Origin. National Research Council of the Philippines. Metro Manila: 1977. 293 pp.

1. A p. vii 51. J p. 71-72 101. D p. 140-143

2. D p. 1 52. I p. 71-72 102. C p. 140-143

3. D p. 1 53. H p. 71-72 103. B p. 140-143

4. D p.2 54. G p. 71-72 104. A p. 140-143

5. D p. 3 55. F p. 71-72 105. J p. 140-143

6. C p. 4-5 56. E p. 71-72 106. I p. 140-143

7. C p. 9 57. D p. 71-72 107. H p. 140-143

8. C p. 11 58. C p. 71-72 108. G p. 140-143

9. C p. 11 59. B p. 71-72 109. F p. 140-143
10. C p. 11 60. A p. 71-72 110. B p. 154
11. C p. 12 61. D p. 76 111. C p. 145
12. C p. 14 62. D p. 76 112. D p. 146
13. C p. 14 63. A p. 77 113. D p. 146
14. D p. 15 64. D 114. D p. 146
15. A p. 17 65. B 115. D p. 146
16. B p. 19 66. A 116. D p. 148
17. D p. 21 67. C 117. A p. 183-186
18. H p. 21 68. J p. 93-94 118. C p. 183-186

19. I p. 41 69. D p. 93-94 119. G p. 183-186

20. E p. 29 70. A p. 93-94 120. F p. 183-186

21. C p. 22 71. G p. 93-94 121. I p. 183-186

22. B p. 38 72. C p. 93-94 122. B p. 183-186
23. F p. 25 73. I p. 93-94 123. H p. 183-186
24. G p. 35 74. B p. 93-94 124. E p. 183-186
25. J p. 25 75. H p. 93-94 125. J p. 183-186
26. D p. 45 76. E p. 93-94 126. D p. 183-186
27. A p. 34 77. F p. 93-94 127. A p. 185
28. A p. 49 78. D p. 97 128. B p. 206
29. B p. 50 79. D p. 97 129. D p. 245-248
30. D p. 52 80. D p. 97 130. E p. 245-248
31. H p. 52-53 81. A p. 98 131. F p. 245-248
32. B p. 52-53 82. D p. 98 132. G p. 245-248
33. I p. 52-53 83. D p.98 133. A p. 245-248
34. C p. 52-53 84. J p. 97-129 134. B p. 245-248
35. A p. 52-53 85. I p. 97-129 135. C p. 245-248
36. J p. 52-53 86. H p. 97-129 136. J p. 245-248
37. D p. 52-53 87. G p. 97-129 137. I p. 245-248
38. E p. 52-53 88. F p. 97-129 138. H p. 245-248
39. G p. 52-52 89. E p. 97-129
40. F p. 52-53 90. D p. 97-129
41. C p. 58 91. C p. 97-129
42. D p. 58 92. B p. 97-129
43. D p. 58 93. A p. 97-129
44. A p. 58 94.D p. 132
45. D p. 64 95. C p. 132
46. B p. 64 96. B p. 132
47. C p. 64 97. A p. 132
48. D p. 64 98. C p. 133
49. A p. 64 99. C p. 133
50. D p. 68 100. E p. 140-143

REFERENCE USED FOR 139-205:

Tyler, Varro E., Brady, Lynn R. and Robbers, James E. Pharmacognosy. 9 th Edition. Lea and
Febriger. Philadelphia: USA. 1988

139. C p. 3 161. E p. 47-54 184. J p. 91

140. D p. 7 162. B p. 47-54 185. D
141. D p. 10 163. D p. 57 186. D p. 82
142. A p. 10 164. A p. 57 187. D p. 82
143. D p.11 165. D p. 57 188. D p. 85
144. B p. 11 166. B p. 57 189. D p. 88
145. C p. 11 167. C p. 58 190. D p. 89
146. A p. 13 168. D p. 58 191. A p.89
147. C p. 13-14 169. A p.59 192. B p. 90
148. D p. 22 170. C p. 59 193. C p. 90
149. C p. 23 171. B p. 60 194. E p. 91
150. A p. 24 172. D p. 62 195. D p. 91
151. B p. 24 173. D p. 62 196. A p. 94
152. C p. 31 174. A p. 63 197. A p. 98
153. D p. 45 175. A p. 64 198. A p. 103
154. D p. 45 176. B p. 64 199. D p. 103
155. C p. 46 177. G p. 64 200. C p. 105
156. A p. 47-54 178. C p. 64 201. D p. 106
157. F p. 47-54 179. I p. 64 202. C p. 107
158. G p. 47-54 180. A p. 66 203. D p. 107
159. D p. 47-54 181. F p. 70 204. C p. 107
160. C p. 47-54 182. H p. 72 205. D p. 108
162. B p. 47-54 183. E p. 78

206. C. biologics (Tyler, p. 24)

207. B. marc (Tyler, p.4)
208 D. drying ensures good keeping qualities, prevent molding, the action of enzymes,
bacteria, chemical or other possible changes. It also fixes the constituents, facilitates grinding
and milling and converts the drug into a more convenient form from commercial handling.
(Tyler, p. 7)
209.A. Quality (Tyler, p. 10)
210.B. taxonomic classification (Tyler, p. 11)
211.C. inert constituents (Tyler, p. 13)
212.A. enzymes and proteins (Tyler, p. 24)
213.D. cellulose (Tyler, p. 26)
214.B. hexoses (Tyler, p. 27)
215.C. skimmed milk (Tyler, p. 34)
216.D. condensed milk ( Tyler, p. 34)
217.A. mannitol (Tyelr, p. 38)
218.B. dextrose (Tyler, p. 42)
219.D. soluble guncotton/pyroxylin (Tyler, p. 45)
220.A. vermiform tragacanth (Tyler, p. 47)
221.C. pectin (Tyler,p. 54)
222.A. Frangula- anthraquinone glycoside (Tyler, p. 59)
223.D. keratolytic (Tyler, p. 66)
224.C. nutgall (Tyler, p. 80)
225.B. saponification value (Tyler, p. 82)
226.C. ethiodized oil injection (Tyler, p. 94)
227.D. (Tyler, p. 96)
228.D. PABA (Para amino benzoic acid) (Tyler, p. 310)
229.C. myrrh
230.B. because morphine contains a phenolic and alcoholic hydroxyl group. (Tyler, p. 217)
231.C. indole alkaloids (Tyler, p. 219)
232.A. ergotamine tartrate (Tyler, p. 235)
233.D. Volatile oils can distilled from their natural sources; do not consist of glyceryl esters of
fatty acids; do not leave a permanent spot or stain on paper and cannot be saponified with
alkalies; do not become rancid and upon exposure to light and air, they oxidize and resinify.
234.D. oxide volatile oil (Tyler, p. 133)
235.C. dopamine is 3,4-dihydroxyphenylethylamine; biosynthetic precursor of norepinephrine
and epinephrine; acts directly to stimulate alpha and beta-1 receptors; used to treat cardiac
decomposition and patients with acute hypotension
236.D. thyroid hyperactivity results in thyrotoxicosis characterized by increased heart rate,
blood pressure, nervous excitability and metabolic rate, muscular weakness with tremor; loss
of body weight and fat and increased tolerance to cold but intolerance to heat. (Tyler, p. 255-
256)
237 A. vasopressin (Tyler, p. 259)
238.D. chorionic gonadotropin (Tyler, p. 262)
239.B. coenzymes (Tyler, p. 273)
240.C. zymase (Tyler,p. 273)
241.C. Steapsin (Tyler,p. 273)
242.B. Bromelain (Tyler, p. 277)
243.B. niacin also known as nicotinic acid or Vitamin B3
244.A. naturally acquired active immunity (Tyler, p. 383)
245.B. resenes (Tyler, p. 140)
246.C. mastic (Tyler, p. 143)
247.B. Provitamin D2 (Tyler, p. 161)
248.A. (Tyler, p. 264)
249.B. Lipase (Tyler, p.273)
250.A. Peroxidases (Tyler, p. 274)
251.C. storax (Tyler. P. 152)
252.A. Steroidal alkaloids (Tyler, p. 238)
253.C. soybean meal (Tyler, p. 90)
254.B. urogonadotropin or menotropins (Tyler, p. 262)
255.A. calcitonin (Tyler, p. 270)
256.A (Gennaro 413)
257. B (Gennaro 413)
258. D (Gennaro 412)
259. A (Gennaro 434)
260. C (Gennaro 415)
261. C (Gennaro 415)
262. C (Dewick 306-307)
 263. C (Dewick 335)
264. D (Gennaro 431)
265. :C (Gennaro 433)
266. A (Dewick 32)
267. D (Gennaro 109)
268. A (Gennaro 40)
269. C (Gennaro 321)
270. A (Dewick 58)
271. C (Dewick 178)
272. C (Dewick 105)
273. B (Dewick 168)
274. B (Tyler, Brady and Robbers 363-364)
275. D (Tyler, Brady and Robbers 357)

REFERENCES:

Dewick PM. 1997. Medicinal Natural Products: A Biosynthetic Approach. Chichester: John Wiley and Sons.

Gennaro AR ed. 2000. Remington: The Science and Practice of Pharmacy. 20th ed. Philadelphia: Lippicott
Williams and Wilkins.

Tyler VE, Brady LR and Robbers JE. 1988. Pharmacognosy. 9th ed. Philadelphia: Lea and Febiger.